J Korean Med Sci.  2008 Dec;23(6):964-968. 10.3346/jkms.2008.23.6.964.

Evaluation of Preterm Delivery between 32(+0)-33(+6) Weeks of Gestation

• Lee SS
• Kwon HS
• Choi HM

• KMID: 1107518
• DOI: http://doi.org/10.3346/jkms.2008.23.6.964

Abstract

Preterm labor after 34 weeks of gestation has shown no great difference from fullterm labor in terms of neonatal morbidity and mortality when proper antepartum management (antibiotics or steroids treatment) is done. However, various studies have discussed different views on the risks and safety of preterm delivery at 32(+0)- 33(+6) weeks of gestation. We evaluated the complications of different preterm groups that included the neonates born at 32(+0)-33(+6) weeks of gestation (142), stratified randomly selected neonates born at 34(+0)-36(+6) weeks of gestation (267) and neonates born after 37(+0) weeks of gestation (356) at our hospital between December 1999 and April 2006. As a result, it was found that neonates born at 3(+0)-36(+6) weeks of gestation showed no great difference from infants born at full term. However, neonates born at 32(+0)-33(+6) weeks were more likely to be admitted to neonatal intensive care unit or develop neonatal complications significantly than the neonates born at 34(+0)- 36(+6) weeks and at full term. Therefore, it is suggested that neonates born at 32(+0)-33(+6) weeks have higher risk of neonatal complications following their preterm labor than those born at later than 34(+0) weeks. Thus, it would be difficult to accept the idea that preterm labor at 32(+0)-33(+6) weeks is safe.

Keyword

Premature Birth; Gestational Weeks; Infant, Newborn

MeSH Terms

Adult
Anti-Bacterial Agents/therapeutic use
Cardiotocography
Chorioamnionitis/etiology
Female
Gestational Age
Humans
Infant, Newborn
Infant, Premature
Infant, Premature, Diseases/*epidemiology
Infant, Small for Gestational Age
Intensive Care Units, Neonatal
Male
Pregnancy
Pregnancy Complications/epidemiology
Premature Birth/mortality
Retrospective Studies
Steroids/therapeutic use

Reference

1. Fuchs F. Prevention of prematurity. Am J Obstet Gynecol. 1976. 126:809–820.

2. Lewit EM, Baker LS, Corman H, Shiono PH. The direct cost of low birth weight. Future Child. 1995. 5:35–56.

3. Ahn JH, Choi HM, Hwang YS, Hong SH, Jung BJ, Jeon MK, Lee ES. Preterm delivery between 34-36 weeks of gestation; is it danger? Korean J Obstet Gynecol. 2002. 45:84–88.

4. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972. 50:515–525.

5. Rush RW, Keirse MJ, Howat P, Baum JD, Anderson AB, Turnbull AC. Contribution of preterm delivery to perinatal mortality. Br Med J. 1976. 2:965–968.

6. Wesselius-de Casparis A, Thiery M, Yo le Sian A, Baumgarten K, Brosens I, Gamisans O, Stolk JG, Vivier W. Results of double-blind, multicentre study with ritodrine in premature labour. Br Med J. 1971. 3:144–147.

7. Ingemarsson I. Effect of terbutaline on premature labor. A double-blind placebo-controlled study. Am J Obstet Gynecol. 1976. 125:520–524.

8. Spellacy WN, Cruz AC, Birk SA, Buhi WC. Treatment of premature labor with ritodrine: a randomized controlled study. Obstet Gynecol. 1979. 54:220–223.

9. Larsen JF, Hansen MK, Hesseldahl H, Kristoffersen K, Larsen PK, Osler M, Weber J, Eldon K, Lange A. Ritodrine in the treatment of preterm labour. A clinical trial to compare a standard treatment with three regimens involving the use of ritodrine. Br J Obstet Gynaecol. 1980. 87:949–957.

10. Larsen JF, Eldon K, Lange AP, Leegaard M, Osler M, Olsen JS, Permin M. Ritodrine in the treatment of preterm labor: second Danish Multicenter Study. Obstet Gynecol. 1986. 67:607–613.

11. Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med. 1992. 327:308–312.

12. Gamissans O, Canas E, Cararach V, Ribas J, Puerto B, Edo A. A study of indomethacin combined with ritodrine in threatened preterm labor. Eur J Obstet Gynecol Reprod Biol. 1978. 8:123–128.

13. Spearing G. Alcohol, indomethacin, and salbutamol. A comparative trial of their use in preterm labor. Obstet Gynecol. 1979. 53:171–174.

14. Niebyl JR, Blake DA, White RD, Kumor KM, Dubin NH, Robinson JC, Egner PG. The inhibition of premature labor with indomethacin. Am J Obstet Gynecol. 1980. 136:1014–1019.

15. Zuckerman H, Shalev E, Gilad G, Katzuni E. Further study of the inhibition of premature labor by indomethacin. Part I. J Perinat Med. 1984. 12:19–23.

16. Stevenson DK, Wright LL, Lemons JA, Oh W, Korones SB, Papile LA, Bauer CR, Stoll BJ, Tyson JE, Shankaran S, Fanaroff AA, Donovan EF, Ehrenkranz RA, Verter J. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol. 1998. 179:1632–1639.

17. Bottoms SF, Paul RH, Mercer BM, MacPherson CA, Caritis SN, Moawad AH, Van Dorsten JP, Hauth JC, Thurnau GR, Miodovnik M, Meis PM, Roberts JM, McNellis D, Iams JD. Obstetric determinants of neonatal survival: antenatal predictors of neonatal survival and morbidity in extremely low birth weight infants. Am J Obstet Gynecol. 1999. 180:665–669.

18. Copper RL, Goldenberg RL, Creasy RK, DuBard MB, Davis RO, Entman SS, Iams JD, Cliver SP. A multicenter study of preterm birth weight and gestational age-specific neonatal mortality. Am J Obstet Gynecol. 1993. 168:78–84.

19. Robertson PA, Sniderman SH, Laros RK Jr, Cowan R, Heilbron D, Goldenberg RL, Iams JD, Creasy RK. Neonatal morbidity according to gestational age and birth weight from five tertiary care centers in the United States, 1983 through 1986. Am J Obstet Gynecol. 1992. 166:1629–1641.

20. Berkman ND, Thorp JM Jr, Lohr KN, Carey TS, Hartmann KE, Gavin NI, Hasselblad V, Idicula AE. Tocolytic treatment for the management of preterm labor: a review of the evidence. Am J Obstet Gynecol. 2003. 188:1648–1659.

21. How HY, Zafaranchi L, Stella CL, Recht K, Maxwell RA, Sibai BM, Spinnato JA. Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: a randomized controlled pilot study. Am J Obstet Gynecol. 2006. 194:976–981.

22. Oh BJ, Lee BG. Epidemiology of the preterm birth. Korean J Obstet Gynecol. 1990. 33:188–201.

23. McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med. 1985. 312:82–90.

24. Jones JS, Istwan NB, Jacques D, Coleman SK, Stanziano G. Is 34 weeks an acceptable goal for a complicated singleton pregnancy? Manag Care. 2002. 11:42–47.

25. Grgić G, Fatusić Z, Bogdanović G. Stimulation of fetal lung maturation with dexamethasone in unexpected premature labor. Med Arh. 2003. 57:291–294.

26. Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS. Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet. 2006. 367:1913–1919.